Back to search

Article

COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trial

2022-08-10

Abstract excerpt

<h4>Objectives</h4> Efficacy of convalescent plasma in COVID-19 pneumonia (CPP) is uncertain, especially in immunocompromised patients. CORIMUNO-CORIPLASM is an open-label, Bayesian randomised clinical trial embedded in the CORIMUNO trials platform that evaluated the efficacy of CCP in patients with moderate COVID-19. <h4>Setting</h4> 19 university and general hospitals across France. <h4>Participants</h4> Adul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3dc45892-cf23-5c63-978f-20535bd23d39
DOI
10.1101/2022.08.09.22278329
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trialDOI 10.1101/2022.08.09.22278329
Select a neighboring publication to make it the new centre.